|
The FDA has approved Sorin Group’s next-generation cardiac resynchronization therapy defibrillator (CRT-D), the Paradym CRT Model 8750.
BOSTON--In the MRI environment under specific guidelines, a new pacemaker system facilitates access to this diagnostic imaging technique with no evidence of clinical (bradycardia or tachycardia), subclinical (pacemaker performance) or technical (pacemaker or lead damage) deficits in patients, according to a late-breaking clinical pivotal trial presented May 14 at the 2009 meeting of the Heart Rhythm Society (HRS).
Written by C.P. Kaiser
Cardiovascular Business invited some of the most prominent physicians in the field of electrophysiology to talk about the current and future state of the subspecialty.
|
Medtronic has received the European CE Mark for its second-generation pacemaker for use with MRI machines, the Advisa DR MRI SureScan pacing system.
BOSTON—Laser-assisted lead removal demonstrated safety and efficacy, based on initial data from the four-year, retrospective LExICon study presented today at the 30th annual scientific sessions of the Heart Rhythm Society (HRS). However, principal investigator Bruce Wilkoff told Cardiovascular Business News that the greatest differentiator in success rates and patient outcomes depends on operator experience.
For survivors of anterior-wall MI who were not candidates for implantation of a cardioverter–defibrillator, access to a home automated external defibrillator (AED) did not significantly improve survival, compared with reliance on conventional resuscitation methods, according to results from the Home Automated External Defibrillator Trial (HAT) presented Tuesday by Gust H. Bardy, MD, at the 2008 American College of Cardiology (ACC) Scientific Sessions in Chicago.
|